Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Exhaled oxidative stress biomarkers and its response to antibiotic treatment in cystic fibrosis (CF) Source: Eur Respir J 2007; 30: Suppl. 51, 31s Year: 2007
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001
Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Source: Eur Respir J 2006; 27: 929-936 Year: 2006
Parameters of oxidative stress in exhaled breath condensate are more pronounced in females then in males with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 728s Year: 2005
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
MicroRNA-26a expression in exhaled breath condensate correlates with pulmonary exacerbation in cystic fibrosis Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001
Prediction of CF exacerbations in children by exhaled inflammation markers Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Inflammatory markers in exhaled breath condensate, assessed by means of Luminex® technology, can differentiate between children with asthma, cystic fibrosis and healthy controls Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007
Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Oxidative stress in expired breath condensate of patients with COPD: relationships with airway inflammation, and disease severity Source: Eur Respir J 2002; 20: Suppl. 38, 284s Year: 2002
Increased nitrosative stress in COPD airways: validation and measurement in exhaled breath condensate Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009